Cargando…
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
Both pre-clinical studies and phase 1–2 clinical trials have provided strong support for the potential role of regional drug delivery in the management of epithelial ovarian cancer, a disease process whose major manifestations remain largely localized to the peritoneal cavity in the majority of indi...
Autor principal: | Markman, Maurie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697524/ https://www.ncbi.nlm.nih.gov/pubmed/19436618 |
Ejemplares similares
-
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?
por: Markman, Maurie
Publicado: (2016) -
Hypersensitivity following Retreatment with Carboplatin a Decade after Completion of Primary Platinum-Based Chemotherapy
por: Williams, Laura, et al.
Publicado: (2009) -
Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
por: Markman, Maurie
Publicado: (2018) -
New developments in the anti-neoplastic drug management of ovarian cancer
por: Markman, Maurie
Publicado: (2013) -
Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancer
por: Markman, Maurie
Publicado: (2010)